Renaud J F, Kazazoglou T, Schmid A, Romey G, Lazdunski M
Eur J Biochem. 1984 Mar 15;139(3):673-81. doi: 10.1111/j.1432-1033.1984.tb08056.x.
The properties of interaction of the Ca2+ channel antagonist [3H]nitrendipine have been investigated in chick hearts at various stages of in ovo and post-natal development and in cultured cells. The dissociation constant of the [3H]nitrendipine-receptor complex is between 0.4 nM and 0.5 nM for intact ventricle and cultured cells. [3H]Nitrendipine binding is antagonized by nitrendipine analogs. The order of efficacy of the different dihydropyridine molecules is nitrendipine greater than nimodipine greater than nifedipine greater than nisoldipine with Kd values ranging from 0.5 to 4 nM. Inhibition of [3H]nitrendipine binding by other antiarrhythmic molecules like amiodarone, F13004 and bepridil was observed. Half-maximum inhibitions (K0.5) were found for verapamil and D600 at concentrations between 0.23 and 0.26 microM. The potency of organic Ca2+ blockers to depress by 50% the maximum amplitude of spontaneous beating of heart cells is closely related to K0.5 values obtained from [3H]nitrendipine binding experiments. Electrophysiological results indicate that the slow channel is insensitive to nitrendipine at the younger stage of development (3-day-old) whereas, in adult like cells, nitrendipine (50 nM) abolished both slow action potential due to the slow Ca2+ channel and contraction. The maximum binding capacity for [3H]nitrendipine is found to increase during development of the embryonic heart from 40 fmol/mg protein at day 3 to 100 fmol/mg protein at day 14, to stay relatively stable until day 18. Then the number of sites increases rapidly to reach a second plateau at 210 fmol/mg protein on day 4 after hatching. Treatment with 6-hydroxydopamine results in 35% increase in [3H]nitrendipine binding, whereas reserpine treatment is without effect. Developmental properties of nitrendipine-sensitive Ca2+ channels have been compared with those of tetrodotoxin-sensitive Na+ channels and muscarinic receptors. These results indicate that nitrendipine receptors exist at the early stage of development (3-day-old-hearts) but that they do not correspond to functional slow Ca2+ channels, that in ovo development corresponds both to an increase of the number of [3H]nitrendipine receptors and to the transformation of silent Ca2+ channels into functional Ca2+ channels, and that there is a regulation of the level nitrendipine-sensitive Ca2+ channels by innervation.
在鸡胚及出生后不同发育阶段的心脏以及培养细胞中,对钙离子通道拮抗剂[3H]尼群地平的相互作用特性进行了研究。对于完整的心室和培养细胞,[3H]尼群地平 - 受体复合物的解离常数在0.4 nM至0.5 nM之间。[3H]尼群地平的结合受到尼群地平类似物的拮抗。不同二氢吡啶分子的效力顺序为:尼群地平大于尼莫地平大于硝苯地平大于尼索地平,其解离常数(Kd)值范围为0.5至4 nM。观察到其他抗心律失常分子如胺碘酮、F13004和苄普地尔对[3H]尼群地平结合的抑制作用。维拉帕米和D600在浓度为0.23至0.26 microM时出现半数抑制(K0.5)。有机钙离子阻滞剂使心脏细胞自发搏动最大振幅降低50%的效力与从[3H]尼群地平结合实验获得的K0.5值密切相关。电生理结果表明,在发育早期(3日龄),慢通道对尼群地平不敏感,而在类似成年细胞中,尼群地平(50 nM)可消除由慢钙离子通道引起的慢动作电位和收缩。发现[3H]尼群地平的最大结合容量在胚胎心脏发育过程中增加,从第3天的40 fmol/mg蛋白质增加到第14天的100 fmol/mg蛋白质,直到第18天保持相对稳定。然后在孵化后第4天,位点数量迅速增加,达到第二个平台期,为210 fmol/mg蛋白质。用6 - 羟基多巴胺处理导致[3H]尼群地平结合增加35%,而利血平处理则无影响。已将尼群地平敏感的钙离子通道的发育特性与河豚毒素敏感的钠离子通道和毒蕈碱受体的发育特性进行了比较。这些结果表明,尼群地平受体在发育早期(3日龄心脏)就已存在,但它们并不对应于功能性慢钙离子通道,胚胎发育既对应于[3H]尼群地平受体数量的增加,也对应于沉默钙离子通道向功能性钙离子通道的转变,并且神经支配对尼群地平敏感的钙离子通道水平存在调节作用。